Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?
Author:
Affiliation:
1. Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London , London , UK
2. Sapphire Medical Clinics , London , UK
Publisher
Oxford University Press (OUP)
Subject
Gastroenterology,Immunology and Allergy
Link
https://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izad221/51721943/izad221.pdf
Reference10 articles.
1. The impact of cannabis use on clinical outcomes in inflammatory bowel disease: a population-based longitudinal cohort study;Glickman;Inflamm Bowel Dis.,2023
2. Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study;Lahat;Digestion.,2012
3. The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry;Dalavaye;Expert Rev Gastroenterol Hepatol,2023
4. Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease;Martinho-Grueber;Eur J Gastroenterol Hepatol,2023
5. Cannabis use in IBD is associated with increased healthcare utilization but not with surgery or death;Loeb;Inflamm Bowel Dis.,2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3